Pressroom

See all trending topics »Trending Topics

Check out the latest cancer-related news and also see who is readily available to offer reliable information, expert commentary, and reaction to today's headlines.
Contact a media coordinator »

Promising New Research at the 2015 AACR Annual Meeting

Memorial Sloan Kettering experts are available to comment on the exciting new research presented at the 2015 American Association of Cancer Research annual meeting, including research in immunotherapy in pediatric cancers and melanoma, breast cancer, and many others. For more information and to set up interviews or access photos and video, email Rebecca Williams at williamr@mskcc.org.

Saturday, April 18, 2015
Exciting Developments, New Research in Breast Cancer: San Antonio Breast Cancer Symposium

Memorial Sloan Kettering breast cancer experts are available to comment on breaking news out of this year’s annual meeting set to take place December 9 through 13.

Monday, December 8, 2014
Major Developments in Hematology-Oncology to Be Reported at ASH Annual Meeting

The largest hematology-oncology meeting in the world will take place in San Francisco from December 6 through 9. Memorial Sloan Kettering experts are available to comment on breaking news out of the meeting.

Tuesday, December 2, 2014

See all press releases »Press Releases

Two Promising Memorial Sloan Kettering Studies Featured at American Association for Cancer Research Annual Meeting

Two encouraging Memorial Sloan Kettering Cancer Center (MSK) studies were featured in this year’s American Association for Cancer Research (AACR) Annual Meeting press program.

Tuesday, April 21, 2015
Research Proves Combination Immunotherapy Significantly More Effective than Ipilimumab Alone for Patients with Advanced Melanoma

Positive results from a clinical trial published in The New England Journal of Medicine show that the combination of the immunotherapy drugs ipilimumab (Yervoy) and nivolumab (Opdivo), produced significantly better outcomes than ipilimumab alone in patients with advanced melanoma. A second piece in the same issue from MSK details a dramatic response occurring after a single dose of the combination therapy.

Monday, April 20, 2015
Memorial Sloan Kettering Opens Pediatric CAR T Cell Clinical Trial

Researchers from Memorial Sloan Kettering Cancer Center (MSK) are pioneering a new groundbreaking clinical trial for children and young adults with relapsed or treatment-resistant acute lymphocytic leukemia (ALL) by using one of the most promising methods of cancer treatment today, chimeric antigen receptor (CAR) T cells.

Thursday, April 9, 2015

See all blog posts »On Our Blog

Ask the Expert
Should I Consider Multigene Panel Testing?

Learn about multigene panel testing and some of its potential pros and cons from one of our experts.

Thursday, April 23, 2015
MSK Physician-in-Chief José Baselga
Announcement
A Sampling of Promising Cancer Science Highlighted at AACR Annual Meeting

MSK physician-scientists reported hopeful news from several clinical studies at the annual meeting of the American Association for Cancer Research.

Tuesday, April 21, 2015
Cancer genomics researcher Timothy Chan
In the Lab
Why a New Immunotherapy for Lung Cancer Works for Only Some People

According to an MSK study, a powerful immunotherapy drug for lung cancer works better in people whose tumors carry a lot of mutations caused by tobacco smoke.

Thursday, April 16, 2015

MSK News Highlights

Watch highlights including news coverage of recent scientific and clinical developments at Memorial Sloan Kettering, our physicians and scientists in the national spotlight, and our amazing staff and programs.

Watch Video »

See all media coverage »Media Coverage

Removal of Ovaries, Fallopian Tubes Wrong Anti-Cancer Option for Most

Gynecologist and geneticist Noah Kauff was interviewed about the oophorectomy procedure and what options are available for women with the BRCA gene.

Friday, March 27, 2015
Why Doctors Are Trying A Skin Cancer Drug To Treat A Brain Tumor

Medical oncologist David Hyman discusses basket studies for NPR Morning Edition.

Thursday, March 26, 2015
NBC Nightly News

Medical oncologists Larry Norton and Ginger Gardner discuss the benefits and the risks of an oophorectomy surgery and quality of life after the procedure for NBC Nightly News.

Wednesday, March 25, 2015

For Journalists

Contact Media Staff

Jeanne D'Agostino
Media Relations Manager
Emily O'Donnell
Senior Communications Associate, Department of Surgery
Courtney Nowak
Senior Media Relations Associate
Caitlin Hool
Senior Media Associate
Nicole H. McNamara
Senior Media Relations Associate
Rebecca Williams
Media Associate

For press inquiries, our Media Staff are available by calling 646-227-3573 or by dialing the numbers above. Our office hours are Monday - Friday, 9:00 AM to 5:00 PM.

After hours, please contact the hospital's page operator at 212-639-7900 and ask for the Public Affairs representative on-call.

#1 in Cancer Care

MSK Named #1 by U.S. News

News & World Report named Memorial Sloan Kettering the top hospital for cancer care in the nation. We're honored, and patient care will always be our top priority.

Live and Remote Broadcast Capabilities

Our experts can offer live broadcast interviews using the on-site studio system. To book an expert interview using our on-site broadcast studio contact our Media Staff.

Subscribe to Our
E-Newsletter

Our e-mail newsletter for journalists offers the latest advances in cancer research and treatment, including story ideas, institutional milestones and plans, and newsworthy staff accomplishments.

Sign Up

Read recent issues »